CPhI Prepares for India - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

CPhI Prepares for India


CPhI ands its collocated events take place in various other locations outside of Europe. Following the event’s departure from Madrid, it will only be a few weeks before pharmaceutical professionals are once again networking under the CPhI name; this time in Mumbai for CPhI India.

CPhI India will take place on 21–23 November at the Bombay Exhibition Centre and will also celebrate its sixth anniversary. According to the organisers, the Indian pharmaceutical market is growing at an annual rate of 13%, twice that of the global market growth rate.

Last year’s event featured 825 exhibitors from 21 countries and regions and more than 27000 attendees from 96 countries and regions. Visitor levels are not far behind CPhI Worldwide, which has been running for considerably longer than its Indian sister event.

CPhI India will also feature some of the same collocated events that are seen at the European show: P-MEC for pharmaceutical machinery, equipment and technology; ICSE for pharmaceutical contract services and outsourcing solutions; and BioPh for bio-solutions for pharma.

You can find out more about CPhI India here.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here